Antiviral effect of double and triple drug combinations amongst HIV‐infected adultslessons from the implementation of viral load‐driven antiretroviral therapy
作者:
Robert Hogg,
Stephanie Rhone,
Benita Yip,
Chris Sherlock,
Brian Conway,
Martin Schechter,
Michael O'Shaughnessy,
Julio Montaner,
期刊:
AIDS
(OVID Available online 1998)
卷期:
Volume 12,
issue 3
页码: 279-284
ISSN:0269-9370
年代: 1998
出版商: OVID
关键词: Zidovudine;didanosine;zalcitabine;lamivudine;stavudine;protease inhibitors;antiretroviral therapy;population-based cohort
数据来源: OVID
摘要:
Objective:To study the antiviral effect and predictors of response to two- and three-drug regimens amongst antiretroviral-naive individuals using an intent-to-treat analysis.Main outcome measure:Suppression of plasma viral load to <500 copies/ml.Patients:A total of 420 (264 double drug, 156 triple drug) individuals in a province-wide treatment programme were studied.Results:A decrease in plasma viral load to < 500 copies/ml was documented in 197 (47%) subjects. This was independently associated with a lower baseline plasma viral load (odds ratio, 3.67; 95% confidence interval, 2.13–6.30) and initiation onto a three-drug regimen (odds ratio, 3.86; 95% confidence interval, 2.24–6.66). Median plasma viral load failed to reach < 500 copies/ml and in fact rebounded in the two-drug group. In contrast, 91 (58%) subjects receiving three drugs reached <500 copies/ml during the study period.Conclusion:These results support the use of powerful triple drug regimens as initial therapy in HIV-infected individuals.
点击下载:
PDF
(153KB)
返 回